BICLUSTER_ID : UPREG-138
PATHOGENS /2/ : pseudomonas aeruginosa,streptococcus pneumoniae
TARGETS /5/ : IL6, PTGS2, LDLR, IL8, SERPINB2
Gene SetLeading Edge Genes
NETPATH IL 1 PATHWAY UPBIRC3, LIF, CXCL1, NFKBIE, TSPYL2, SERPINB2, CXCL3, FOSL1, NFKBIA, IL6, PTGS2, INHBA, IL8, CXCL2
NETPATH TNF ALPHA PATHWAY DOWNCXCL1, CXCL3, NFKBIA, MAFF, IL6, PTGS2, TNFAIP3, CXCL2, BHLHB2, IER3
NETPATH IL 6 PATHWAY UPSGK, MAFF, GADD45B, CXCL1, CEBPD, LDLR, MAP3K8, BHLHB2
GENTILE UV RESPONSE CLUSTER D2
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
MAHAJAN RESPONSE TO IL1A UP
BIOCARTA IL6 PATHWAY
VARELA ZMPSTE24 TARGETS UP
TENEDINI MEGAKARYOCYTE MARKERS
LINDSTEDT DENDRITIC CELL MATURATION B
MCBRYAN PUBERTAL BREAST 4 5WK UP
RASHI RESPONSE TO IONIZING RADIATION 2
LINDSTEDT DENDRITIC CELL MATURATION A
LIEN BREAST CARCINOMA METAPLASTIC VS DUCTAL UP
ELVIDGE HYPOXIA UP
IYENGAR RESPONSE TO ADIPOCYTE FACTORS
AMIT EGF RESPONSE 40 HELA
NETPATH IL 7 PATHWAY UP
TOMIDA METASTASIS UP
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 5
JEON SMAD6 TARGETS UP
MITSIADES RESPONSE TO APLIDIN UP
TURASHVILI BREAST NORMAL DUCTAL VS LOBULAR UP
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
NCI IL6 7PATHWAY
LIN SILENCED BY TUMOR MICROENVIRONMENT
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION SUSTAINDED IN ERYTHROCYTE UP
BOYAULT LIVER CANCER SUBCLASS G56 DN
HINATA NFKB TARGETS KERATINOCYTE UP
KOKKINAKIS METHIONINE DEPRIVATION 96HR UP
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
DAZARD UV RESPONSE CLUSTER G3
AMIT EGF RESPONSE 240 MCF10A
OSADA ASCL1 TARGETS DN
AMIT SERUM RESPONSE 60 MCF10A
DUTTA APOPTOSIS VIA NFKB
COULOUARN TEMPORAL TGFB1 SIGNATURE UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS MAGENTA UP
NCI MYC REPRESSPATHWAY
TSAI RESPONSE TO IONIZING RADIATION
CORUM RIBOSOME CYTOPLASMIC
DIRMEIER LMP1 RESPONSE EARLY
LANDIS ERBB2 BREAST TUMORS 324 UP
MCBRYAN PUBERTAL BREAST 3 4WK UP
RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY DN
AMIT SERUM RESPONSE 240 MCF10A
NCI REG GR PATHWAY
BIOCARTA CD40 PATHWAY
BIOCARTA ETS PATHWAY
ZHOU INFLAMMATORY RESPONSE LIVE UP
ONDER CDH1 TARGETS 3 DN
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS BLUE UP
AMIT EGF RESPONSE 120 HELA
DEBOSSCHER NFKB TARGETS REPRESSED BY GLUCOCORTICOIDS
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS RED UP
BIOCARTA RANKL PATHWAY
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
WINTER HYPOXIA METAGENE
NEWMAN ERCC6 TARGETS UP
SHAFFER IRF4 TARGETS IN PLASMA CELL VS MATURE B LYMPHOCYTE
PODAR RESPONSE TO ADAPHOSTIN UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS TURQUOISE UP
FOSTER INFLAMMATORY RESPONSE LPS DN
LEE LIVER CANCER E2F1 UP
NCI VIRAL MRNA TRANSLATION
TAVOR CEBPA TARGETS UP
REACTOME VIRAL MRNA TRANSLATION
WANG SMARCE1 TARGETS DN
KERLEY RESPONSE TO CISPLATIN UP
NCI EUKARYOTIC TRANSLATION TERMINATION
OSAWA TNF TARGETS
NCI PEPTIDE CHAIN ELONGATION
SATO SILENCED BY DEACETYLATION IN PANCREATIC CANCER
BIOCARTA CARDIACEGF PATHWAY
LAU APOPTOSIS CDKN2A UP
NETPATH TGFBETA RECEPTOR PATHWAY DOWN
NGUYEN NOTCH1 TARGETS DN
WINTER HYPOXIA UP
AMIT SERUM RESPONSE 120 MCF10A
BROWNE HCMV INFECTION 2HR UP
CORUM REL-MAP3K8-RELA-TNIP2-PAPOLA COMPLEX
PUIFFE INVASION INHIBITED BY ASCITES DN
SESTO RESPONSE TO UV C3
VERHAAK AML WITH NPM1 MUTATED UP
BROCKE APOPTOSIS REVERSED BY IL6
GEISS RESPONSE TO DSRNA UP
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
GERY CEBP TARGETS
NCI P53DOWNSTREAMPATHWAY
ST TUMOR NECROSIS FACTOR PATHWAY
TIAN TNF SIGNALING VIA NFKB
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
CORUM SMAD3-SMAD4-CJUN-CFOS COMPLEX
AMIT DELAYED EARLY GENES
KRIGE AMINO ACID DEPRIVATION
AMIT EGF RESPONSE 60 MCF10A
HINATA NFKB TARGETS FIBROBLAST UP
RHEIN ALL GLUCOCORTICOID THERAPY UP
MISSIAGLIA REGULATED BY METHYLATION UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
NCI TCRCALCIUMPATHWAY
LEONARD HYPOXIA
NCI FORMATION OF A POOL OF FREE 40S SUBUNITS
SESTO RESPONSE TO UV C1
CROONQUIST STROMAL STIMULATION UP
BERENJENO TRANSFORMED BY RHOA REVERSIBLY DN
HALMOS CEBPA TARGETS UP
CHANDRAN METASTASIS DN
BIOCARTA CDMAC PATHWAY
NCI CMYB PATHWAY
AMIT EGF RESPONSE 480 MCF10A
MAHADEVAN RESPONSE TO MP470 DN
DORN ADENOVIRUS INFECTION 12HR DN
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 DN
NCI LYSOPHOSPHOLIPID PATHWAY
HARRIS HYPOXIA
HUPER BREAST BASAL VS LUMINAL DN
TURASHVILI BREAST DUCTAL CARCINOMA VS DUCTAL NORMAL DN
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
KOKKINAKIS METHIONINE DEPRIVATION 48HR UP
BASSO CD40 SIGNALING UP
BIOCARTA NTHI PATHWAY
NAGASHIMA NRG1 SIGNALING UP
SOUCEK MYC TARGETS
MARZEC IL2 SIGNALING UP
ENK UV RESPONSE EPIDERMIS DN
REACTOME TOLL LIKE RECEPTOR 3 CASCADE
ZERBINI RESPONSE TO SULINDAC UP
SCIAN INVERSED TARGETS OF TP53 AND TP73 DN
WANG ESOPHAGUS CANCER VS NORMAL UP
FRIDMAN SENESCENCE UP
REACTOME TRAF6 MEDIATED INDUCTION OF THE ANTIVIRAL CYTOKINE IFN ALPHA BETA CASCADE
FERRARI RESPONSE TO FENRETINIDE UP
SHAFFER IRF4 MULTIPLE MYELOMA PROGRAM
BILD HRAS ONCOGENIC SIGNATURE
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
NCI ENDOTHELINPATHWAY
NCI TCRRASPATHWAY
LEE LIVER CANCER ACOX1 UP
MENSE HYPOXIA UPCLK3, CEBPD, KLF4, ANGPTL4, MAFF, PDK1, ATF3, BHLHB2
REACTOME PEPTIDE CHAIN ELONGATION
WU HBX TARGETS 1 UP
BERENJENO TRANSFORMED BY RHOA FOREVER DN
KANNAN TP53 TARGETS UP
CHEN HOXA5 TARGETS 9HR UP
DAZARD UV RESPONSE CLUSTER G2
NETPATH IL 5 PATHWAY UP
WANG RECURRENT LIVER CANCER DN
DORN ADENOVIRUS INFECTION 24HR UP
SEKI INFLAMMATORY RESPONSE LPS UP
NETPATH EGFR1 PATHWAY UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
CONCANNON APOPTOSIS BY EPOXOMICIN UP
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
PARK TRETINOIN RESPONSE AND PML RARA FUSION
MURAKAMI UV RESPONSE 6HR UP
BIERIE INFLAMMATORY RESPONSE TGFB1
BUYTAERT PHOTODYNAMIC THERAPY STRESS UP
SENESE HDAC1 AND HDAC2 TARGETS UP
WANG METHYLATED IN BREAST CANCER
AMIT EGF RESPONSE 240 HELA
ONDER CDH1 TARGETS 2 DN
SENESE HDAC1 TARGETS UP
ODONNELL TARGETS OF MYC AND TFRC UP
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
KIM WT1 TARGETS UP
SENESE HDAC3 TARGETS UP
ONDER CDH1 TARGETS 1 DN
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
XU HGF SIGNALING NOT VIA AKT1 6HR
BIOCARTA KERATINOCYTE PATHWAY
DASU IL6 SIGNALING UP
ELVIDGE HYPOXIA BY DMOG UP
NETPATH IL 2 PATHWAY UP
BIOCARTA IL2RB PATHWAY
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
REACTOME FORMATION OF A POOL OF FREE 40S SUBUNITS
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
ZUCCHI METASTASIS DN
BRUECKNER TARGETS OF MIRLET7A3 UP
PRAMOONJAGO SOX4 TARGETS UP
KOBAYASHI RESPONSE TO ROMIDEPSIN
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
pseudomonas aeruginosa fdr440streptococcus pneumoniae g54streptococcus pneumoniae tigr4GeneSet Name
0.00000 0.02186 0.00001NETPATH_IL_1_PATHWAY_UP
0.01426 0.00809 0.00000NETPATH_TNF_ALPHA_PATHWAY_DOWN
0.03716 0.01842 0.00000NETPATH_IL_6_PATHWAY_UP
0.09404 0.02049 0.03475GENTILE_UV_RESPONSE_CLUSTER_D2
0.01700 0.03257 0.00058GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.00044 0.08911 0.00006MAHAJAN_RESPONSE_TO_IL1A_UP
0.09012 0.06093 0.01655BIOCARTA_IL6_PATHWAY
0.05018 0.01900 0.00000VARELA_ZMPSTE24_TARGETS_UP
0.05310 0.11247 0.00292TENEDINI_MEGAKARYOCYTE_MARKERS
0.00000 0.00817 0.00796LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.11152 0.03294 0.02036MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
0.00000 0.00271 0.00000RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.00003 0.16372 0.15403LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.00347 0.04813 0.02026LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.16459 0.00034 0.00000ELVIDGE_HYPOXIA_UP
0.00064 0.03272 0.08439IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
0.15015 0.02615 0.00000AMIT_EGF_RESPONSE_40_HELA
0.00003 0.11486 0.00009NETPATH_IL_7_PATHWAY_UP
0.17251 0.02419 0.00109TOMIDA_METASTASIS_UP
0.06558 0.03309 0.00224YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.00005 0.02288 0.11902JEON_SMAD6_TARGETS_UP
0.01817 0.00669 0.00323MITSIADES_RESPONSE_TO_APLIDIN_UP
0.11423 0.02057 0.06018TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP
0.00052 0.09013 0.00077THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.14730 0.10802 0.00381NCI_IL6_7PATHWAY
0.11173 0.01665 0.00206LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT
0.11741 0.13995 0.07760TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.06129 0.14828 0.00024TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.00799 0.12091 0.00130BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN
0.00000 0.00568 0.00741HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.05096 0.02436 0.00726KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.00034 0.17463 0.02561KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.01564 0.03860 0.03617DAZARD_UV_RESPONSE_CLUSTER_G3
0.00513 0.03825 0.00691AMIT_EGF_RESPONSE_240_MCF10A
0.11392 0.03295 0.09859OSADA_ASCL1_TARGETS_DN
0.01060 0.00321 0.00000AMIT_SERUM_RESPONSE_60_MCF10A
0.00513 0.05455 0.00090DUTTA_APOPTOSIS_VIA_NFKB
0.02348 0.00641 0.02113COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP
0.04178 0.00558 0.00000GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP
0.13310 0.17907 0.06003NCI_MYC_REPRESSPATHWAY
0.04793 0.03105 0.03596TSAI_RESPONSE_TO_IONIZING_RADIATION
0.00000 0.04216 0.09762CORUM_RIBOSOME_CYTOPLASMIC
0.00002 0.08905 0.00000DIRMEIER_LMP1_RESPONSE_EARLY
0.17275 0.04149 0.02274LANDIS_ERBB2_BREAST_TUMORS_324_UP
0.16505 0.04431 0.05498MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
0.00883 0.00390 0.11158RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
0.00002 0.01938 0.07436AMIT_SERUM_RESPONSE_240_MCF10A
0.01860 0.05556 0.01495NCI_REG_GR_PATHWAY
0.00500 0.09309 0.06184BIOCARTA_CD40_PATHWAY
0.11257 0.12208 0.04543BIOCARTA_ETS_PATHWAY
0.00010 0.11282 0.00172ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.00194 0.03102 0.00000ONDER_CDH1_TARGETS_3_DN
0.02769 0.01216 0.00000GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
0.00068 0.01466 0.00000AMIT_EGF_RESPONSE_120_HELA
0.02560 0.15437 0.18502DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS
0.07493 0.09080 0.19787GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP
0.01277 0.11238 0.05739BIOCARTA_RANKL_PATHWAY
0.01078 0.13119 0.05863NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.00135 0.01549 0.00002WINTER_HYPOXIA_METAGENE
0.03524 0.04821 0.07628NEWMAN_ERCC6_TARGETS_UP
0.09246 0.03041 0.00114SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
0.13382 0.00016 0.00000PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.12253 0.01570 0.00001GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
0.00037 0.01680 0.01424FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.16834 0.05639 0.09181LEE_LIVER_CANCER_E2F1_UP
0.00000 0.06641 0.08297NCI_VIRAL_MRNA_TRANSLATION
0.08516 0.04868 0.01378TAVOR_CEBPA_TARGETS_UP
0.00000 0.06578 0.07641REACTOME_VIRAL_MRNA_TRANSLATION
0.01270 0.03606 0.01452WANG_SMARCE1_TARGETS_DN
0.19127 0.01965 0.00312KERLEY_RESPONSE_TO_CISPLATIN_UP
0.00000 0.04420 0.09169NCI_EUKARYOTIC_TRANSLATION_TERMINATION
0.00149 0.00719 0.04111OSAWA_TNF_TARGETS
0.00000 0.04545 0.08238NCI_PEPTIDE_CHAIN_ELONGATION
0.01084 0.02405 0.00028SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.00769 0.13908 0.00718BIOCARTA_CARDIACEGF_PATHWAY
0.00130 0.01015 0.00272LAU_APOPTOSIS_CDKN2A_UP
0.12159 0.14788 0.05146NETPATH_TGFBETA_RECEPTOR_PATHWAY_DOWN
0.11301 0.01647 0.08108NGUYEN_NOTCH1_TARGETS_DN
0.06929 0.01824 0.08413WINTER_HYPOXIA_UP
0.02960 0.00320 0.00000AMIT_SERUM_RESPONSE_120_MCF10A
0.00002 0.04469 0.00000BROWNE_HCMV_INFECTION_2HR_UP
0.16848 0.08343 0.11125CORUM_REL-MAP3K8-RELA-TNIP2-PAPOLA_COMPLEX
0.14437 0.00111 0.02022PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN
0.02538 0.01104 0.00000SESTO_RESPONSE_TO_UV_C3
0.00218 0.12533 0.01022VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.04896 0.09635 0.00015BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.00007 0.03258 0.03793GEISS_RESPONSE_TO_DSRNA_UP
0.03950 0.03598 0.00170GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.00131 0.12493 0.00001GERY_CEBP_TARGETS
0.02164 0.06541 0.00000NCI_P53DOWNSTREAMPATHWAY
0.00001 0.10551 0.10060ST_TUMOR_NECROSIS_FACTOR_PATHWAY
0.00000 0.16057 0.00001TIAN_TNF_SIGNALING_VIA_NFKB
0.00243 0.06587 0.01752LEE_LIVER_CANCER_HEPATOBLAST
0.00002 0.00045 0.00000NAGASHIMA_EGF_SIGNALING_UP
0.14807 0.06969 0.04867CORUM_SMAD3-SMAD4-CJUN-CFOS_COMPLEX
0.04277 0.01300 0.00000AMIT_DELAYED_EARLY_GENES
0.08532 0.04467 0.00068KRIGE_AMINO_ACID_DEPRIVATION
0.00027 0.00090 0.00000AMIT_EGF_RESPONSE_60_MCF10A
0.00000 0.02432 0.00038HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.11161 0.05094 0.00381RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
0.00000 0.00810 0.05746MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.01991 0.01189 0.00812SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.00010 0.01878 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.08874 0.15695 0.00024NCI_TCRCALCIUMPATHWAY
0.00131 0.00548 0.00001LEONARD_HYPOXIA
0.00000 0.05058 0.09078NCI_FORMATION_OF_A_POOL_OF_FREE_40S_SUBUNITS
0.00240 0.00828 0.00117SESTO_RESPONSE_TO_UV_C1
0.00017 0.09861 0.00000CROONQUIST_STROMAL_STIMULATION_UP
0.19008 0.11462 0.00179BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN
0.00031 0.02527 0.00000HALMOS_CEBPA_TARGETS_UP
0.06578 0.15824 0.00003CHANDRAN_METASTASIS_DN
0.00516 0.16806 0.00114BIOCARTA_CDMAC_PATHWAY
0.06914 0.01518 0.12428NCI_CMYB_PATHWAY
0.00220 0.10254 0.14948AMIT_EGF_RESPONSE_480_MCF10A
0.02760 0.15502 0.00000MAHADEVAN_RESPONSE_TO_MP470_DN
0.00157 0.10988 0.00432DORN_ADENOVIRUS_INFECTION_12HR_DN
0.08542 0.02167 0.07890CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.06542 0.17451 0.01481NCI_LYSOPHOSPHOLIPID_PATHWAY
0.00003 0.10031 0.00000HARRIS_HYPOXIA
0.05090 0.11468 0.14163HUPER_BREAST_BASAL_VS_LUMINAL_DN
0.00130 0.01840 0.10905TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.00448 0.01803 0.00002DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.01727 0.02323 0.00577KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
0.00000 0.03498 0.01887BASSO_CD40_SIGNALING_UP
0.00021 0.04158 0.14147BIOCARTA_NTHI_PATHWAY
0.00002 0.00022 0.00000NAGASHIMA_NRG1_SIGNALING_UP
0.02994 0.08229 0.02991SOUCEK_MYC_TARGETS
0.01502 0.16651 0.01084MARZEC_IL2_SIGNALING_UP
0.02173 0.00387 0.00050ENK_UV_RESPONSE_EPIDERMIS_DN
0.06330 0.04826 0.06070REACTOME_TOLL_LIKE_RECEPTOR_3_CASCADE
0.03840 0.09092 0.00038ZERBINI_RESPONSE_TO_SULINDAC_UP
0.11869 0.08263 0.12713SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN
0.00878 0.10110 0.16764WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.00103 0.03706 0.06538FRIDMAN_SENESCENCE_UP
0.18304 0.03113 0.02267REACTOME_TRAF6_MEDIATED_INDUCTION_OF_THE_ANTIVIRAL_CYTOKINE_IFN_ALPHA_BETA_CASCADE
0.00002 0.01205 0.00024FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.15531 0.09034 0.02086SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
0.00028 0.00093 0.00000BILD_HRAS_ONCOGENIC_SIGNATURE
0.00005 0.01216 0.13850LIANG_SILENCED_BY_METHYLATION_2
0.00085 0.03237 0.00000DAUER_STAT3_TARGETS_UP
0.16436 0.08884 0.15079NCI_ENDOTHELINPATHWAY
0.06112 0.09052 0.01846NCI_TCRRASPATHWAY
0.13286 0.05921 0.10301LEE_LIVER_CANCER_ACOX1_UP
0.05632 0.00004 0.00000MENSE_HYPOXIA_UP
0.00000 0.04336 0.08109REACTOME_PEPTIDE_CHAIN_ELONGATION
0.02293 0.07559 0.00585WU_HBX_TARGETS_1_UP
0.11486 0.02282 0.00046BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.13379 0.00648 0.00146KANNAN_TP53_TARGETS_UP
0.00550 0.00050 0.00003CHEN_HOXA5_TARGETS_9HR_UP
0.00228 0.03619 0.00000DAZARD_UV_RESPONSE_CLUSTER_G2
0.00726 0.07746 0.00002NETPATH_IL_5_PATHWAY_UP
0.10298 0.05148 0.01420WANG_RECURRENT_LIVER_CANCER_DN
0.12901 0.17059 0.15513DORN_ADENOVIRUS_INFECTION_24HR_UP
0.00000 0.02093 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.00005 0.11210 0.00000NETPATH_EGFR1_PATHWAY_UP
0.00002 0.11160 0.00000GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.03175 0.01005 0.00250CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.00000 0.00231 0.00001ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.06632 0.15242 0.14027PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
0.15080 0.16966 0.02795MURAKAMI_UV_RESPONSE_6HR_UP
0.00969 0.05057 0.00416BIERIE_INFLAMMATORY_RESPONSE_TGFB1
0.06733 0.00031 0.00109BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
0.00002 0.15156 0.05989SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.06554 0.02474 0.00000WANG_METHYLATED_IN_BREAST_CANCER
0.01646 0.08012 0.15294AMIT_EGF_RESPONSE_240_HELA
0.00005 0.00297 0.10479ONDER_CDH1_TARGETS_2_DN
0.00013 0.05349 0.08992SENESE_HDAC1_TARGETS_UP
0.19863 0.19023 0.02726ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
0.00011 0.00067 0.00000HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.00002 0.00273 0.00001KIM_WT1_TARGETS_UP
0.01005 0.03264 0.11682SENESE_HDAC3_TARGETS_UP
0.00709 0.07758 0.00114ONDER_CDH1_TARGETS_1_DN
0.02749 0.00000 0.00000UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.00558 0.06148 0.09671XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.00633 0.06149 0.04968BIOCARTA_KERATINOCYTE_PATHWAY
0.00711 0.09369 0.00007DASU_IL6_SIGNALING_UP
0.15685 0.00018 0.00000ELVIDGE_HYPOXIA_BY_DMOG_UP
0.00843 0.16635 0.07061NETPATH_IL_2_PATHWAY_UP
0.12600 0.01752 0.13947BIOCARTA_IL2RB_PATHWAY
0.00000 0.03864 0.00000GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.00000 0.04813 0.08242REACTOME_FORMATION_OF_A_POOL_OF_FREE_40S_SUBUNITS
0.00011 0.01851 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.00002 0.01824 0.00000ZUCCHI_METASTASIS_DN
0.12920 0.00087 0.01685BRUECKNER_TARGETS_OF_MIRLET7A3_UP
0.00044 0.00000 0.00000PRAMOONJAGO_SOX4_TARGETS_UP
0.13806 0.03353 0.03910KOBAYASHI_RESPONSE_TO_ROMIDEPSIN
0.06556 0.00267 0.00000PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN